Cached score snapshot

US.BAX · Baxter International

110分制 49.2/110；5D動能v2 9/50；排序分 58.2/160

Back to ranking Open volume snapshot

Ranking score 58.2/160

Main score 49.2/110

5D momentum v2 9/50

Rank #313

Setup grade F 26

Score breakdown

避免

Elevated database-backfill

Score and price trend

F 26 Elevated risk

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

**Historical projection**
Model	Median	P25/P75	歷史相似情境上漲比例	Down5	Actual / compare
Rolling DOE best · score 1.738 · anchors 52	-0.65%	-2.67% / +1.41%	42.5%	10%	Actual +4.78% · vs median +5.43% · inside 25-75 band
Historical projection 10D n=160	-0.20%	-2.02% / +1.77%	46.3%	8.8%	Actual -1.40% · vs median -1.20% · inside 25-75 band

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-01-02 → 2026-07-08 · 128 archived points · 1 Improving turn signal · 1 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 58.2

Display grade 避免

Model version cursor_18_27_news_v2_160

Main score 49.2/110 (避免)

5D momentum v2 9/50 (弱)

Score with momentum v2 58.2/160 (低排序)

Risk level Elevated

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 153

ma20 19.9925

ma50 19.2466

close 20.07

prevClose 19.73

avgVolume20 8942815

volumeRatio 0.82

changePercent 1.72

Metrics snapshot

close 20.07

volume 7301500

changePercent 1.72

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 49.2/110

Main rating 避免

5D momentum v2 9/50

Score with momentum v2 58.2/160

Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 2.1/5 · 較差

Dimension score 2.1/5

Dimension grade 較差

Sub-items

pbPoints 0.5

pePoints 0

epsPoints 0

roePoints 0

debtPoints 0.4

marginPoints 0

turnoverUsdM 146.5411

volumePoints 0.5

revenuePoints 0

dividendPoints 0.3

marketCapPoints 0.4

資金流 — 9.2/20 · 較差

Dimension score 9.2/20

Dimension grade 較差

Sub-items

cmfPoints 1.6

mfiPoints 0.8

obvPoints 2.4

vwapPoints 2.4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL

symbol US.BAX

message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.

optional true

holderCount n/a

holderPoints 2

top10ShareRatio n/a

concentrationPenalty 0

institutionPoints 2

市場環境 — 9.4/15 · 一般

Dimension score 9.4/15

Dimension grade 一般

Sub-items

vix

score 2.4

details

source twelvedata+fred+database-backfill-market-proxy

vixClose 17.44

trend

score 3.4

details

qqq

ma20 122.7198

ma50 120.5085

name QQQ

close 122.0185

points 1.4

spy

ma20 113.7324

ma50 111.3364

name SPY

close 113.8334

points 2

source twelvedata+fred+database-backfill-market-proxy

atrPct 3.1888

atrPoints 2

cciPoints 1.6

vixPoints 2.4

marketTrendPoints 3.4

催化劑 — 2/20 · 較差

Dimension score 2/20

Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model

articleCount 8

catalystCount 0

catalystPoints 2

風險管理 — 6.3/10 · 一般

Dimension score 6.3/10

Dimension grade 一般

Sub-items

position

score 1.1

details

atrPct 3.1888

turnoverUsdM 146.5411

liquidityPoints 0.4

volatilityPoints 0.7

rrPoints 1.4

stopLevels

symbol US.BAX

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 18.79

strength_details

ma_score 1.5

atr_score 1

rsi_score 2.5

macd_score 1.5

volume_score 1

market_adjustment 1

risk_reward_ratio 1

stop_loss_percent 6.4

take_profit_price 21.3063

target_multiplier 1.9

technical_strength 1.53

take_profit_percent 6.2

positionPoints 1.1

stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.2

stopLossPercent 6.3777

diversificationPoints 2

技術信號 — 18.2/30 · 一般

Dimension score 18.2/30

Dimension grade 一般

Sub-items

bbPoints 3

adxPoints 3

sarPoints 1.2

vcpPoints 2.7

macdPoints 2.4

vcpPayload

vcp_pass true

vcp_score 2.7

vcp_reason 波幅收縮(13%→6.1%)；跌縮量(近10日4日)；站上MA50；升放量(近10日2日)；Ready=Y；Confirm=Y

vcp_metrics

up_days 4

vol_ref 8274040

down_days 5

vcp_ready true

above_ma50 true

avg_vol_10 7929900

avg_vol_20 8830970

avg_vol_30 8274040

range_pct_10 0.0613

range_pct_20 0.1101

range_pct_30 0.1295

up_expand_ok true

lookback_used 79

near_20d_high true

contraction_ok true

down_shrink_ok true

up_expand_days 2

breakout_20d_ok false

vol_ratio_10_30 0.9584

dist_to_20d_high 0.0555

down_shrink_days 4

breakout_level_20d 21.25

vcp_breakout_confirm true

contraction_ratio_10_30 0.4731

vcp_name_en Volatility Contraction Pattern

vcp_name_zh 波動收縮形態

vol_contraction true

kdjAdxPoints 0.7

rsiKdjPoints 1.6

volumeWeight 2

maCrossPoints 1.6

shortRsiPoints 0.8

shortMacdPoints 0.4

volConfirmPoints 0

volumePointsTechnical 0.8

情緒分析 — 2/10 · 較差

Dimension score 2/10

Dimension grade 較差

Sub-items

sentiment

score 2

details

source finnhub_news_keyword_model

articleCount 8

negativeHits 1

positiveHits 1

sentimentScoreRaw 0

sentimentData

raw {"id":140634742,"url":"https://finnhub.io/api/news?id=0892bd0085212e506bbe0c5d8de4133eb48096c600318d5302fefa1d40e5ca20","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Wondering whether Baxter International at US$20.86 is a bargain or a value trap? This article breaks down what the current share price might be telling you about the stock. The stock has risen 7.6% over the past week and 20.6% over the past month, yet is still down 7.0% year to date and has declined 31.3% over the last year. This raises questions about how the market now views its risk and potential. Recent coverage has focused on Baxter International's position within the medical equipment...","category":"company","datetime":1781485867,"headline":"Baxter (BAX) Stock After Recent Rebound Is The Discount To DCF Value Warranted"}, {"id":140633632,"url":"https://finnhub.io/api/news?id=c921549dc90d1629f35d5baeeb770705845f25df3c8da0d41ea763a07153820c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Baxter International (BAX) has attracted fresh attention after recent trading, with the stock showing double digit returns over the past month and past 3 months. This performance is prompting investors to reassess its current valuation. See our latest analysis for Baxter International. The recent move takes Baxter International's share price to US$20.86, with share price returns of 20.58% over 30 days and 22.13% over 90 days, while the 1 year total shareholder return has declined 31.29%. This...","category":"company","datetime":1781460292,"headline":"Baxter International (BAX) Stock Valuation Check After Recent Double Digit Gains And Ongoing Turnaround Plans"}, {"id":140613330,"url":"https://finnhub.io/api/news?id=b63af62eef8967c92f6666527a86a99781b9ca4507d2ea60c657e409d4170585","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Is BAX a good stock to buy? We came across a bullish thesis on Baxter International Inc. on Heavy Moat Investments’s Substack. In this article, we will summarize the bulls’ thesis on BAX. Baxter International Inc.’s share was trading at $20.03 as of June 9th. BAX’s forward P/E was 10.20 according to Yahoo Finance. Baxter International (BAX) […]","category":"company","datetime":1781208892,"headline":"Is Baxter International Inc. (BAX) A Good Stock To Buy Now?"}, {"id":140590539,"url":"https://finnhub.io/api/news?id=0eb9086f72c8109d5c268ac958cd4ad0dc57dc6797fe0ebbaef24701379bf555","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"With a TTM operating cash flow of $1.25 billion, Baxter International Inc. (NYSE:BAX) is included among the 12 Cash-Rich Stocks to Buy Right Now. On May 28, Citi analyst Joanne Wuensch downgraded Baxter International Inc. (NYSE:BAX) to Sell from Neutral. She lowered the price target on the stock to $17 from $19. In a research note, the […]","category":"company","datetime":1781064084,"headline":"Baxter International (BAX) Faces Tough Road Ahead, Says Citi in Downgrade"}, {"id":140583945,"url":"https://finnhub.io/api/news?id=2db814eac48c944fa37591bfb5df54189064f9e6afa0144622e3399b16aa059e","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"BAX","summary":"Baxter International Inc. (BAX) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 9, 2026 11:20 AM EDTCompany ParticipantsKevin Moran - Vice...","category":"company","datetime":1781016130,"headline":"Baxter International Inc. (BAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript"}, {"id":140453276,"url":"https://finnhub.io/api/news?id=e0e6c760d9c3e0d2d6e7f0d63b38529f5a50accadb8609272f444c7a1db92bac","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Shares of healthcare company Baxter International (NYSE:BAX) fell 1% in the morning session after Citigroup downgraded the stock to Sell from Neutral and lowered its price target to $17.","category":"company","datetime":1780015080,"headline":"Why Baxter (BAX) Shares Are Sliding Today"}, {"id":140452772,"url":"https://finnhub.io/api/news?id=71b87f930e00b6bd4b3eb13fe1ea877b5de757b51ae4a3a29e6187e7c6020bcf","image":"","source":"Fintel","related":"BAX","summary":"","category":"company","datetime":1780012972,"headline":"Citigroup Downgrades Baxter International (BAX)"}, {"id":140403005,"url":"https://finnhub.io/api/news?id=37d9c6634fcb7e16c0a76ef2247f2e3e118da51fcd387f1d995b8f7a8de355ff","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Wondering whether Baxter International at around US$19.18 is a bargain or a value trap? This article walks through what the current price might actually imply. The stock has moved sharply in the short term, with a 10.9% gain over the past week and 5.6% over the past month, despite being down 1.6% year to date and declining 35.5% over the past year and 50.2% over three years. These moves sit against an ongoing evergreen interest in Baxter International as a large healthcare equipment company...","category":"company","datetime":1779603074,"headline":"Has Baxter International (BAX) Overreacted After Recent 10.9% Weekly Share Price Jump"}

raw_source {"id":140670840,"url":"https://finnhub.io/api/news?id=c6a7812f159ccb5aaef45ee570ae7d8e2b9f14fd8e26006ea81049dde42451b5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"BAX gains as Synovis MCA signs a multi-year deal to commercialize MediThinQ's SHIYA 3D surgical visualization platform worldwide.","category":"company","datetime":1781878980,"headline":"Baxter's Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform"}, {"id":140666038,"url":"https://finnhub.io/api/news?id=25b7a9de4a65701a132014a8a9b8adc240aad40f4e19c80e5ad27f3cc09b630f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ECG Patch and Holter Monitor Market size & share revenue was valued at approximately USD 1.87 Billion in 2025 and is expected to reach USD 2.04 Billion in 2026 and is expected to reach around USD 3.92 Billion by 2035, at a CAGR of 9.2% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are iRhythm Technologies","category":"company","datetime":1781814600,"headline":"Global ECG Patch and Holter Monitor Market Size/Share Worth USD 3.92 Billion by 2035 at a 9.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)"}, {"id":140664070,"url":"https://finnhub.io/api/news?id=6d9943dc90e818f99e50146e5d1610165de152f4f7714dcf9fcf8ff7f8cb4118","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Closed System Drug Transfer Devices Market size & share revenue was valued at approximately USD 1.47 Billion in 2025 and is expected to reach USD 1.58 Billion in 2026 and is expected to reach around USD 3.21 Billion by 2035, at a CAGR of 8.3% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are BD (Becton Dic","category":"company","datetime":1781803800,"headline":"Global Closed System Drug Transfer Devices Market Size/Share Worth USD 3.21 Billion by 2035 at a 8.3% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)"}, {"id":140663297,"url":"https://finnhub.io/api/news?id=adc27b3fb4139d69f3dcfd2b0a213ac6e37b497c9f7c978c5347984016455e47","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"MediThinQ, a South Korea-based innovator in surgical visualization technologies, has entered into an exclusive multi-year distribution agreement with Synovis Micro Companies Alliance, Inc. (\"Synovis MCA\"), a subsidiary of Baxter International Inc. (NYSE:BAX) and trusted leader in microsurgical devices and solutions, to commercialize SHIYA, its 3D surgical visualization platform. Terms of this agreement were not disclosed.","category":"company","datetime":1781791260,"headline":"MediThinQ and Synovis Micro Companies Alliance, Inc. Announce Strategic Global Distribution Agreement to Redefine Microsurgery with the SHIYA 3D Visualization Platform"}, {"id":140659123,"url":"https://finnhub.io/api/news?id=6500a89609145bb6f717162dde7cd7ffab56e4c31bb69cad9dd053575d82ba64","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Due to Baxter International's underperformance relative to the S&P 500 over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.","category":"company","datetime":1781718696,"headline":"Is Baxter International Stock Underperforming the S&P 500?"}, {"id":140648039,"url":"https://finnhub.io/api/news?id=15d6a6da3b9d3800527810852b9cb36443de1cbe24001fad935a1b3e373c974f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"BAX is pursuing a broad turnaround as innovation, resilient demand, and AI integration support recovery despite regulatory risks and margin pressure.","category":"company","datetime":1781633640,"headline":"Reasons to Retain Baxter International Stock in Your Portfolio for Now"}, {"id":140634742,"url":"https://finnhub.io/api/news?id=0892bd0085212e506bbe0c5d8de4133eb48096c600318d5302fefa1d40e5ca20","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Wondering whether Baxter International at US$20.86 is a bargain or a value trap? This article breaks down what the current share price might be telling you about the stock. The stock has risen 7.6% over the past week and 20.6% over the past month, yet is still down 7.0% year to date and has declined 31.3% over the last year. This raises questions about how the market now views its risk and potential. Recent coverage has focused on Baxter International's position within the medical equipment...","category":"company","datetime":1781485867,"headline":"Baxter (BAX) Stock After Recent Rebound Is The Discount To DCF Value Warranted"}, {"id":140633632,"url":"https://finnhub.io/api/news?id=c921549dc90d1629f35d5baeeb770705845f25df3c8da0d41ea763a07153820c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Baxter International (BAX) has attracted fresh attention after recent trading, with the stock showing double digit returns over the past month and past 3 months. This performance is prompting investors to reassess its current valuation. See our latest analysis for Baxter International. The recent move takes Baxter International's share price to US$20.86, with share price returns of 20.58% over 30 days and 22.13% over 90 days, while the 1 year total shareholder return has declined 31.29%. This...","category":"company","datetime":1781460292,"headline":"Baxter International (BAX) Stock Valuation Check After Recent Double Digit Gains And Ongoing Turnaround Plans"}, {"id":140617550,"url":"https://finnhub.io/api/news?id=f76577ccd2afa9f62ff300b9d61ae05f983c127e543779f36991e9f8dc42e989","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.","category":"company","datetime":1781266400,"headline":"3 Unpopular Stocks We’re Skeptical Of"}, {"id":140613330,"url":"https://finnhub.io/api/news?id=b63af62eef8967c92f6666527a86a99781b9ca4507d2ea60c657e409d4170585","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Is BAX a good stock to buy? We came across a bullish thesis on Baxter International Inc. on Heavy Moat Investments’s Substack. In this article, we will summarize the bulls’ thesis on BAX. Baxter International Inc.’s share was trading at $20.03 as of June 9th. BAX’s forward P/E was 10.20 according to Yahoo Finance. Baxter International (BAX) […]","category":"company","datetime":1781208892,"headline":"Is Baxter International Inc. (BAX) A Good Stock To Buy Now?"}, {"id":140612479,"url":"https://finnhub.io/api/news?id=7f1c2bffc66a2f605adfd7ba0b96f3f1dcd66bc180defb70e5ee21946e4718c9","image":"","source":"Benzinga","related":"BAX","summary":"https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-positive-pressure-breathing-device-issue-baxter","category":"company","datetime":1781183128,"headline":"FDA Issues Early Alert Regarding Pressure Breathing Device Issue from Baxter"}, {"id":140596066,"url":"https://finnhub.io/api/news?id=6de6f4e4a12e861915f3d06383c086645b033ef96ce3d87691eeae9b696d7c73","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"DVA expands its IKC platform, tops CKCC savings in first-quarter 2026 and rolls out AI ScheduleHub to boost scheduling and staffing.","category":"company","datetime":1781110440,"headline":"DaVita Stock Gains From Integrated Kidney Care and CKCC Progress"}, {"id":140590539,"url":"https://finnhub.io/api/news?id=0eb9086f72c8109d5c268ac958cd4ad0dc57dc6797fe0ebbaef24701379bf555","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"With a TTM operating cash flow of $1.25 billion, Baxter International Inc. (NYSE:BAX) is included among the 12 Cash-Rich Stocks to Buy Right Now. On May 28, Citi analyst Joanne Wuensch downgraded Baxter International Inc. (NYSE:BAX) to Sell from Neutral. She lowered the price target on the stock to $17 from $19. In a research note, the […]","category":"company","datetime":1781064084,"headline":"Baxter International (BAX) Faces Tough Road Ahead, Says Citi in Downgrade"}, {"id":140583945,"url":"https://finnhub.io/api/news?id=2db814eac48c944fa37591bfb5df54189064f9e6afa0144622e3399b16aa059e","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"BAX","summary":"Baxter International Inc. (BAX) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 9, 2026 11:20 AM EDTCompany ParticipantsKevin Moran - Vice...","category":"company","datetime":1781016130,"headline":"Baxter International Inc. (BAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript"}, {"id":140572907,"url":"https://finnhub.io/api/news?id=b1c37ae647672013d1823dd30fb5ca0c86b20292e3feb2d68cf83360e1ed1b46","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"FMS scales 5008X high-volume HDF and expands home dialysis, aiming for benefits later in 2026 and a bigger payoff in 2027+.","category":"company","datetime":1780944660,"headline":"FMS and Home Dialysis: How 5008X Could Reset Demand"}, {"id":140453276,"url":"https://finnhub.io/api/news?id=e0e6c760d9c3e0d2d6e7f0d63b38529f5a50accadb8609272f444c7a1db92bac","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Shares of healthcare company Baxter International (NYSE:BAX) fell 1% in the morning session after Citigroup downgraded the stock to Sell from Neutral and lowered its price target to $17.","category":"company","datetime":1780015080,"headline":"Why Baxter (BAX) Shares Are Sliding Today"}, {"id":140452772,"url":"https://finnhub.io/api/news?id=71b87f930e00b6bd4b3eb13fe1ea877b5de757b51ae4a3a29e6187e7c6020bcf","image":"","source":"Fintel","related":"BAX","summary":"","category":"company","datetime":1780012972,"headline":"Citigroup Downgrades Baxter International (BAX)"}, {"id":140449207,"url":"https://finnhub.io/api/news?id=bc8f2cde021f6c8a927983f08c8ab1a2f28e21ce28e5527cf4d43f88ad5022fb","image":"","source":"Benzinga","related":"BAX","summary":"Citigroup analyst Joanne Wuensch downgrades Baxter International (NYSE:BAX) from Neutral to Sell and lowers the price target from $19 to $17.","category":"company","datetime":1779973793,"headline":"Citigroup Downgrades Baxter International to Sell, Lowers Price Target to $17"}, {"id":140446338,"url":"https://finnhub.io/api/news?id=39ef101458a5b010a2ae3ea9e4b435ff840c909190792b0a685bd77c440cd322","image":"https://image.cnbcfm.com/api/v1/image/108313321-17799871461779987144-46215767070-1080pnbcnews.jpg?v=1779987146&w=1920&h=1080","source":"CNBC","related":"BAX","summary":"Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's \"Halftime Report\" to detail Ritholt's new \"Porterhouse\" strategy. Josh also spotlights Edwards Lifesciences in his \"Best Stocks in the Market.\"","category":"company","datetime":1779973172,"headline":"Josh Brown's 'best stocks in the market': Edwards Lifesciences"}, {"id":140443064,"url":"https://finnhub.io/api/news?id=739400f7a1c3b0ae772d83f88fccf1c0ff5da2056bd2587fef5d8a5e9c627cd0","image":"https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp","source":"ChartMill","related":"BAX","summary":"Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.","category":"company","datetime":1779971700,"headline":"Discover the top S&P500 movers in Thursday's pre-market session."}, {"id":140403005,"url":"https://finnhub.io/api/news?id=37d9c6634fcb7e16c0a76ef2247f2e3e118da51fcd387f1d995b8f7a8de355ff","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Wondering whether Baxter International at around US$19.18 is a bargain or a value trap? This article walks through what the current price might actually imply. The stock has moved sharply in the short term, with a 10.9% gain over the past week and 5.6% over the past month, despite being down 1.6% year to date and declining 35.5% over the past year and 50.2% over three years. These moves sit against an ongoing evergreen interest in Baxter International as a large healthcare equipment company...","category":"company","datetime":1779603074,"headline":"Has Baxter International (BAX) Overreacted After Recent 10.9% Weekly Share Price Jump"}, {"id":140398553,"url":"https://finnhub.io/api/news?id=9535be8c14cea2cdff6790fa37156ad01c3493764fc54c8f0d765dfc17e1d6bd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.","category":"company","datetime":1779547495,"headline":"1 Stock Under $50 Worth Investigating and 2 Facing Challenges"}

data_source finnhub_news_keyword_model

article_count 8

negative_hits 1

positive_hits 1

recomputed_at_score true

sentiment_score_raw 0

source_article_count 22

discarded_article_count 14

sentimentPoints 2

Dimension contribution

Dimension Raw Max Norm % Contrib

基本面 2.1 5/110 42% 2.1

資金流 9.2 20/110 46% 9.2

市場環境 9.4 15/110 62.67% 9.4

催化劑 2 20/110 10% 2

風險管理 6.3 10/110 63% 6.3

技術信號 18.2 30/110 60.67% 18.2

情緒分析 2 10/110 20% 2

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 9/50

ret_5d 0.0116

max_score 50

max_total 50

raw_total 9

vcp_bonus 2

vol_ratio 0.8268

ret_points 4

vol_points 0

range_ratio 0.9582

volat_points 0

day_range_pct 0.0289

model_version cursor_18_27_news_v2_160

available_bars 30

breakout_points 0

partial_history false

pullback_points 3

breakout_vol_bonus 0

first_breakout_20d false

return_window_days 5

first_breakout_bonus 0

breakout_quality_points 0

Risk management

level Elevated

reason risk management score >= 5/10

position

score 1.1

details

atrPct 3.1888

turnoverUsdM 146.5411

liquidityPoints 0.4

volatilityPoints 0.7

rrPoints 1.4

stopLevels

symbol US.BAX

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 18.79

strength_details

ma_score 1.5

atr_score 1

rsi_score 2.5

macd_score 1.5

volume_score 1

market_adjustment 1

risk_reward_ratio 1

stop_loss_percent 6.4

take_profit_price 21.3063

target_multiplier 1.9

technical_strength 1.53

take_profit_percent 6.2

positionPoints 1.1

stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.2

stopLossPercent 6.3777

diversificationPoints 2

Calculation audit log

基本面分析總分: 2.1/5分
資金流分析總分: 9.2/20分
市場環境分析總分: 9.4/15分
催化劑分析: 2/20分
風險管理總分: 6.3/10分
技術信號分析總分: 18.2/30分
情緒分析: 2/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx

value 85.71

atr

atr 0.64

rule ATR / current price; lower volatility scores higher

score 4

atr_pct 3.19

cci

rule Cursor_18.24 CCI bands

level 弱勢

score 4

value -4.67

cmf

rule Cursor_18.24 CMF bands

level 平衡

score 4

value 0.0469

kdj

d 35.37

j 62.65

k 44.47

rule Cursor_18.24 K/D cross

score 4

signal 金叉

mfi

rule Cursor_18.24 MFI bands

level 超賣或超買風險

score 2

value 36.57

obv

rule Cursor_18.24 recent_slope vs previous_slope

score 6

trend 有流入

value 1232300

recentSlope 901800

previousSlope 2481490

rsi

value 39.63

sar

rule Cursor_18.24 Parabolic SAR

score 4

trend 下降

value 20.8256

position SAR喺價上

distancePct 3.76

previousTrend 下降

ma50

value 19.2466

macd

macd 0.091

trend 中性偏多

signal 0.1389

histogram -0.048

vwap

rule Cursor_18.24 VWAP 20D consecutive close

score 6

value 20.0464

position 連續1-2日>VWAP

consecutiveAbove 1

volume

rule Cursor_18.24 volume ratio

level 無力

ratio 0.82

score 4

avgVolume 8942815

currentVolume 7301500

derived

ma20 19.9925

ma50 19.2466

prevClose 19.73

avgVolume10 7768630

avgVolume20 8942815

changePercent 1.72

avgVolumeForScore 8942815

ma_cross

ma20 19.9925

ma50 19.2466

rule Cursor_18.24 MA20/MA50 cross

cross 多頭

score 4

prevMa20 19.9445

prevMa50 19.2006

spreadPct 3.88

isVolumeBreakout false

bollinger

lower 19.1322

upper 20.8528

position 上半部

rsi_short

value 50

macd_short

macd 0

trend 中性

signal 0

histogram 0

volume_ratio

ratio 0.82

Raw calculation JSON

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.1,
      "details": {
        "atrPct": 3.188839063278525,
        "turnoverUsdM": 146.541105,
        "liquidityPoints": 0.4,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.BAX",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 18.79,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 2.5,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 6.4,
      "take_profit_price": 21.3063,
      "target_multiplier": 1.9,
      "technical_strength": 1.53,
      "take_profit_percent": 6.2
    },
    "positionPoints": 1.1,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 6.37767812655705,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 58.2,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 49.2,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 9
  },
  "market": {
    "ma20": 19.9925,
    "ma50": 19.2466,
    "close": 20.07,
    "prevClose": 19.73,
    "avgVolume20": 8942815,
    "volumeRatio": 0.82,
    "changePercent": 1.72
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred+database-backfill-market-proxy"
  },
  "barCount": 153,
  "momentum": {
    "max": 50,
    "result": 9,
    "details": {
      "ret_5d": 0.011592741935483986,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 9,
      "vcp_bonus": 2,
      "vol_ratio": 0.8268061152965076,
      "ret_points": 4,
      "vol_points": 0,
      "range_ratio": 0.9582366507541662,
      "volat_points": 0,
      "day_range_pct": 0.028898854010961726,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 58.2,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.1,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 42,
        "contribution": 2.1
      },
      {
        "raw": 9.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 46,
        "contribution": 9.2
      },
      {
        "raw": 9.4,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 62.67,
        "contribution": 9.4
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.3,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 63,
        "contribution": 6.3
      },
      {
        "raw": 18.2,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 60.67,
        "contribution": 18.2
      },
      {
        "raw": 2,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 20,
        "contribution": 2
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 49.2,
    "details": [
      "基本面分析總分: 2.1/5分",
      "資金流分析總分: 9.2/20分",
      "市場環境分析總分: 9.4/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.3/10分",
      "技術信號分析總分: 18.2/30分",
      "情緒分析: 2/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.1,
      "資金流": 9.2,
      "市場環境": 9.4,
      "情緒分析": 2,
      "技術信號": 18.2,
      "風險管理": 6.3
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.4,
          "marginPoints": 0,
          "turnoverUsdM": 146.541105,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.4
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 0.8,
          "obvPoints": 2.4,
          "vwapPoints": 2.4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.BAX",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred+database-backfill-market-proxy",
              "vixClose": 17.44
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 122.71975415803759,
                "ma50": 120.50851573611779,
                "name": "QQQ",
                "close": 122.01852006429496,
                "points": 1.4
              },
              "spy": {
                "ma20": 113.73241478495547,
                "ma50": 111.3363639924325,
                "name": "SPY",
                "close": 113.83340038085466,
                "points": 2
              },
              "source": "twelvedata+fred+database-backfill-market-proxy"
            }
          },
          "atrPct": 3.188839063278525,
          "atrPoints": 2,
          "cciPoints": 1.6,
          "vixPoints": 2.4,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 1,
              "positiveHits": 1,
              "sentimentScoreRaw": 0
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140634742,
                "url": "https://finnhub.io/api/news?id=0892bd0085212e506bbe0c5d8de4133eb48096c600318d5302fefa1d40e5ca20",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Wondering whether Baxter International at US$20.86 is a bargain or a value trap? This article breaks down what the current share price might be telling you about the stock. The stock has risen 7.6% over the past week and 20.6% over the past month, yet is still down 7.0% year to date and has declined 31.3% over the last year. This raises questions about how the market now views its risk and potential. Recent coverage has focused on Baxter International's position within the medical equipment...",
                "category": "company",
                "datetime": 1781485867,
                "headline": "Baxter (BAX) Stock After Recent Rebound Is The Discount To DCF Value Warranted"
              },
              {
                "id": 140633632,
                "url": "https://finnhub.io/api/news?id=c921549dc90d1629f35d5baeeb770705845f25df3c8da0d41ea763a07153820c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Baxter International (BAX) has attracted fresh attention after recent trading, with the stock showing double digit returns over the past month and past 3 months. This performance is prompting investors to reassess its current valuation. See our latest analysis for Baxter International. The recent move takes Baxter International's share price to US$20.86, with share price returns of 20.58% over 30 days and 22.13% over 90 days, while the 1 year total shareholder return has declined 31.29%. This...",
                "category": "company",
                "datetime": 1781460292,
                "headline": "Baxter International (BAX) Stock Valuation Check After Recent Double Digit Gains And Ongoing Turnaround Plans"
              },
              {
                "id": 140613330,
                "url": "https://finnhub.io/api/news?id=b63af62eef8967c92f6666527a86a99781b9ca4507d2ea60c657e409d4170585",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Is BAX a good stock to buy? We came across a bullish thesis on Baxter International Inc. on Heavy Moat Investments’s Substack. In this article, we will summarize the bulls’ thesis on BAX. Baxter International Inc.’s share was trading at $20.03 as of June 9th. BAX’s forward P/E was 10.20 according to Yahoo Finance. Baxter International (BAX) […]",
                "category": "company",
                "datetime": 1781208892,
                "headline": "Is Baxter International Inc. (BAX) A Good Stock To Buy Now?"
              },
              {
                "id": 140590539,
                "url": "https://finnhub.io/api/news?id=0eb9086f72c8109d5c268ac958cd4ad0dc57dc6797fe0ebbaef24701379bf555",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "With a TTM operating cash flow of $1.25 billion, Baxter International Inc. (NYSE:BAX) is included among the 12 Cash-Rich Stocks to Buy Right Now. On May 28, Citi analyst Joanne Wuensch downgraded Baxter International Inc. (NYSE:BAX) to Sell from Neutral. She lowered the price target on the stock to $17 from $19. In a research note, the […]",
                "category": "company",
                "datetime": 1781064084,
                "headline": "Baxter International (BAX) Faces Tough Road Ahead, Says Citi in Downgrade"
              },
              {
                "id": 140583945,
                "url": "https://finnhub.io/api/news?id=2db814eac48c944fa37591bfb5df54189064f9e6afa0144622e3399b16aa059e",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "BAX",
                "summary": "Baxter International Inc. (BAX) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 9, 2026 11:20 AM EDTCompany ParticipantsKevin Moran - Vice...",
                "category": "company",
                "datetime": 1781016130,
                "headline": "Baxter International Inc. (BAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript"
              },
              {
                "id": 140453276,
                "url": "https://finnhub.io/api/news?id=e0e6c760d9c3e0d2d6e7f0d63b38529f5a50accadb8609272f444c7a1db92bac",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Shares of healthcare company Baxter International (NYSE:BAX) fell 1% in the morning session after Citigroup downgraded the stock to Sell from Neutral and lowered its price target to $17.",
                "category": "company",
                "datetime": 1780015080,
                "headline": "Why Baxter (BAX) Shares Are Sliding Today"
              },
              {
                "id": 140452772,
                "url": "https://finnhub.io/api/news?id=71b87f930e00b6bd4b3eb13fe1ea877b5de757b51ae4a3a29e6187e7c6020bcf",
                "image": "",
                "source": "Fintel",
                "related": "BAX",
                "summary": "",
                "category": "company",
                "datetime": 1780012972,
                "headline": "Citigroup Downgrades Baxter International (BAX)"
              },
              {
                "id": 140403005,
                "url": "https://finnhub.io/api/news?id=37d9c6634fcb7e16c0a76ef2247f2e3e118da51fcd387f1d995b8f7a8de355ff",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Wondering whether Baxter International at around US$19.18 is a bargain or a value trap? This article walks through what the current price might actually imply. The stock has moved sharply in the short term, with a 10.9% gain over the past week and 5.6% over the past month, despite being down 1.6% year to date and declining 35.5% over the past year and 50.2% over three years. These moves sit against an ongoing evergreen interest in Baxter International as a large healthcare equipment company...",
                "category": "company",
                "datetime": 1779603074,
                "headline": "Has Baxter International (BAX) Overreacted After Recent 10.9% Weekly Share Price Jump"
              }
            ],
            "raw_source": [
              {
                "id": 140670840,
                "url": "https://finnhub.io/api/news?id=c6a7812f159ccb5aaef45ee570ae7d8e2b9f14fd8e26006ea81049dde42451b5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "BAX gains as Synovis MCA signs a multi-year deal to commercialize MediThinQ's SHIYA 3D surgical visualization platform worldwide.",
                "category": "company",
                "datetime": 1781878980,
                "headline": "Baxter's Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform"
              },
              {
                "id": 140666038,
                "url": "https://finnhub.io/api/news?id=25b7a9de4a65701a132014a8a9b8adc240aad40f4e19c80e5ad27f3cc09b630f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ECG Patch and Holter Monitor Market size & share revenue was valued at approximately USD 1.87 Billion in 2025 and is expected to reach USD 2.04 Billion in 2026 and is expected to reach around USD 3.92 Billion by 2035, at a CAGR of 9.2% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are iRhythm Technologies",
                "category": "company",
                "datetime": 1781814600,
                "headline": "Global ECG Patch and Holter Monitor Market Size/Share Worth USD 3.92 Billion by 2035 at a 9.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)"
              },
              {
                "id": 140664070,
                "url": "https://finnhub.io/api/news?id=6d9943dc90e818f99e50146e5d1610165de152f4f7714dcf9fcf8ff7f8cb4118",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Closed System Drug Transfer Devices Market size & share revenue was valued at approximately USD 1.47 Billion in 2025 and is expected to reach USD 1.58 Billion in 2026 and is expected to reach around USD 3.21 Billion by 2035, at a CAGR of 8.3% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are BD (Becton Dic",
                "category": "company",
                "datetime": 1781803800,
                "headline": "Global Closed System Drug Transfer Devices Market Size/Share Worth USD 3.21 Billion by 2035 at a 8.3% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)"
              },
              {
                "id": 140663297,
                "url": "https://finnhub.io/api/news?id=adc27b3fb4139d69f3dcfd2b0a213ac6e37b497c9f7c978c5347984016455e47",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "MediThinQ, a South Korea-based innovator in surgical visualization technologies, has entered into an exclusive multi-year distribution agreement with Synovis Micro Companies Alliance, Inc. (\"Synovis MCA\"), a subsidiary of Baxter International Inc. (NYSE:BAX) and trusted leader in microsurgical devices and solutions, to commercialize SHIYA, its 3D surgical visualization platform. Terms of this agreement were not disclosed.",
                "category": "company",
                "datetime": 1781791260,
                "headline": "MediThinQ and Synovis Micro Companies Alliance, Inc. Announce Strategic Global Distribution Agreement to Redefine Microsurgery with the SHIYA 3D Visualization Platform"
              },
              {
                "id": 140659123,
                "url": "https://finnhub.io/api/news?id=6500a89609145bb6f717162dde7cd7ffab56e4c31bb69cad9dd053575d82ba64",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Due to Baxter International's underperformance relative to the S&P 500 over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.",
                "category": "company",
                "datetime": 1781718696,
                "headline": "Is Baxter International Stock Underperforming the S&P 500?"
              },
              {
                "id": 140648039,
                "url": "https://finnhub.io/api/news?id=15d6a6da3b9d3800527810852b9cb36443de1cbe24001fad935a1b3e373c974f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "BAX is pursuing a broad turnaround as innovation, resilient demand, and AI integration support recovery despite regulatory risks and margin pressure.",
                "category": "company",
                "datetime": 1781633640,
                "headline": "Reasons to Retain Baxter International Stock in Your Portfolio for Now"
              },
              {
                "id": 140634742,
                "url": "https://finnhub.io/api/news?id=0892bd0085212e506bbe0c5d8de4133eb48096c600318d5302fefa1d40e5ca20",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Wondering whether Baxter International at US$20.86 is a bargain or a value trap? This article breaks down what the current share price might be telling you about the stock. The stock has risen 7.6% over the past week and 20.6% over the past month, yet is still down 7.0% year to date and has declined 31.3% over the last year. This raises questions about how the market now views its risk and potential. Recent coverage has focused on Baxter International's position within the medical equipment...",
                "category": "company",
                "datetime": 1781485867,
                "headline": "Baxter (BAX) Stock After Recent Rebound Is The Discount To DCF Value Warranted"
              },
              {
                "id": 140633632,
                "url": "https://finnhub.io/api/news?id=c921549dc90d1629f35d5baeeb770705845f25df3c8da0d41ea763a07153820c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Baxter International (BAX) has attracted fresh attention after recent trading, with the stock showing double digit returns over the past month and past 3 months. This performance is prompting investors to reassess its current valuation. See our latest analysis for Baxter International. The recent move takes Baxter International's share price to US$20.86, with share price returns of 20.58% over 30 days and 22.13% over 90 days, while the 1 year total shareholder return has declined 31.29%. This...",
                "category": "company",
                "datetime": 1781460292,
                "headline": "Baxter International (BAX) Stock Valuation Check After Recent Double Digit Gains And Ongoing Turnaround Plans"
              },
              {
                "id": 140617550,
                "url": "https://finnhub.io/api/news?id=f76577ccd2afa9f62ff300b9d61ae05f983c127e543779f36991e9f8dc42e989",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.",
                "category": "company",
                "datetime": 1781266400,
                "headline": "3 Unpopular Stocks We’re Skeptical Of"
              },
              {
                "id": 140613330,
                "url": "https://finnhub.io/api/news?id=b63af62eef8967c92f6666527a86a99781b9ca4507d2ea60c657e409d4170585",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Is BAX a good stock to buy? We came across a bullish thesis on Baxter International Inc. on Heavy Moat Investments’s Substack. In this article, we will summarize the bulls’ thesis on BAX. Baxter International Inc.’s share was trading at $20.03 as of June 9th. BAX’s forward P/E was 10.20 according to Yahoo Finance. Baxter International (BAX) […]",
                "category": "company",
                "datetime": 1781208892,
                "headline": "Is Baxter International Inc. (BAX) A Good Stock To Buy Now?"
              },
              {
                "id": 140612479,
                "url": "https://finnhub.io/api/news?id=7f1c2bffc66a2f605adfd7ba0b96f3f1dcd66bc180defb70e5ee21946e4718c9",
                "image": "",
                "source": "Benzinga",
                "related": "BAX",
                "summary": "https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-positive-pressure-breathing-device-issue-baxter",
                "category": "company",
                "datetime": 1781183128,
                "headline": "FDA Issues Early Alert Regarding Pressure Breathing Device Issue from Baxter"
              },
              {
                "id": 140596066,
                "url": "https://finnhub.io/api/news?id=6de6f4e4a12e861915f3d06383c086645b033ef96ce3d87691eeae9b696d7c73",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "DVA expands its IKC platform, tops CKCC savings in first-quarter 2026 and rolls out AI ScheduleHub to boost scheduling and staffing.",
                "category": "company",
                "datetime": 1781110440,
                "headline": "DaVita Stock Gains From Integrated Kidney Care and CKCC Progress"
              },
              {
                "id": 140590539,
                "url": "https://finnhub.io/api/news?id=0eb9086f72c8109d5c268ac958cd4ad0dc57dc6797fe0ebbaef24701379bf555",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "With a TTM operating cash flow of $1.25 billion, Baxter International Inc. (NYSE:BAX) is included among the 12 Cash-Rich Stocks to Buy Right Now. On May 28, Citi analyst Joanne Wuensch downgraded Baxter International Inc. (NYSE:BAX) to Sell from Neutral. She lowered the price target on the stock to $17 from $19. In a research note, the […]",
                "category": "company",
                "datetime": 1781064084,
                "headline": "Baxter International (BAX) Faces Tough Road Ahead, Says Citi in Downgrade"
              },
              {
                "id": 140583945,
                "url": "https://finnhub.io/api/news?id=2db814eac48c944fa37591bfb5df54189064f9e6afa0144622e3399b16aa059e",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "BAX",
                "summary": "Baxter International Inc. (BAX) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 9, 2026 11:20 AM EDTCompany ParticipantsKevin Moran - Vice...",
                "category": "company",
                "datetime": 1781016130,
                "headline": "Baxter International Inc. (BAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript"
              },
              {
                "id": 140572907,
                "url": "https://finnhub.io/api/news?id=b1c37ae647672013d1823dd30fb5ca0c86b20292e3feb2d68cf83360e1ed1b46",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "FMS scales 5008X high-volume HDF and expands home dialysis, aiming for benefits later in 2026 and a bigger payoff in 2027+.",
                "category": "company",
                "datetime": 1780944660,
                "headline": "FMS and Home Dialysis: How 5008X Could Reset Demand"
              },
              {
                "id": 140453276,
                "url": "https://finnhub.io/api/news?id=e0e6c760d9c3e0d2d6e7f0d63b38529f5a50accadb8609272f444c7a1db92bac",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Shares of healthcare company Baxter International (NYSE:BAX) fell 1% in the morning session after Citigroup downgraded the stock to Sell from Neutral and lowered its price target to $17.",
                "category": "company",
                "datetime": 1780015080,
                "headline": "Why Baxter (BAX) Shares Are Sliding Today"
              },
              {
                "id": 140452772,
                "url": "https://finnhub.io/api/news?id=71b87f930e00b6bd4b3eb13fe1ea877b5de757b51ae4a3a29e6187e7c6020bcf",
                "image": "",
                "source": "Fintel",
                "related": "BAX",
                "summary": "",
                "category": "company",
                "datetime": 1780012972,
                "headline": "Citigroup Downgrades Baxter International (BAX)"
              },
              {
                "id": 140449207,
                "url": "https://finnhub.io/api/news?id=bc8f2cde021f6c8a927983f08c8ab1a2f28e21ce28e5527cf4d43f88ad5022fb",
                "image": "",
                "source": "Benzinga",
                "related": "BAX",
                "summary": "Citigroup  analyst Joanne Wuensch   downgrades Baxter International (NYSE:BAX) from Neutral to Sell and lowers the price target from $19 to $17.",
                "category": "company",
                "datetime": 1779973793,
                "headline": "Citigroup Downgrades Baxter International to Sell, Lowers Price Target to $17"
              },
              {
                "id": 140446338,
                "url": "https://finnhub.io/api/news?id=39ef101458a5b010a2ae3ea9e4b435ff840c909190792b0a685bd77c440cd322",
                "image": "https://image.cnbcfm.com/api/v1/image/108313321-17799871461779987144-46215767070-1080pnbcnews.jpg?v=1779987146&w=1920&h=1080",
                "source": "CNBC",
                "related": "BAX",
                "summary": "Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's \"Halftime Report\" to detail Ritholt's new \"Porterhouse\" strategy. Josh also spotlights Edwards Lifesciences in his \"Best Stocks in the Market.\"",
                "category": "company",
                "datetime": 1779973172,
                "headline": "Josh Brown's 'best stocks in the market': Edwards Lifesciences"
              },
              {
                "id": 140443064,
                "url": "https://finnhub.io/api/news?id=739400f7a1c3b0ae772d83f88fccf1c0ff5da2056bd2587fef5d8a5e9c627cd0",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "BAX",
                "summary": "Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.",
                "category": "company",
                "datetime": 1779971700,
                "headline": "Discover the top S&P500 movers in Thursday's pre-market session."
              },
              {
                "id": 140403005,
                "url": "https://finnhub.io/api/news?id=37d9c6634fcb7e16c0a76ef2247f2e3e118da51fcd387f1d995b8f7a8de355ff",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Wondering whether Baxter International at around US$19.18 is a bargain or a value trap? This article walks through what the current price might actually imply. The stock has moved sharply in the short term, with a 10.9% gain over the past week and 5.6% over the past month, despite being down 1.6% year to date and declining 35.5% over the past year and 50.2% over three years. These moves sit against an ongoing evergreen interest in Baxter International as a large healthcare equipment company...",
                "category": "company",
                "datetime": 1779603074,
                "headline": "Has Baxter International (BAX) Overreacted After Recent 10.9% Weekly Share Price Jump"
              },
              {
                "id": 140398553,
                "url": "https://finnhub.io/api/news?id=9535be8c14cea2cdff6790fa37156ad01c3493764fc54c8f0d765dfc17e1d6bd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.",
                "category": "company",
                "datetime": 1779547495,
                "headline": "1 Stock Under $50 Worth Investigating and 2 Facing Challenges"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 1,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0,
            "source_article_count": 22,
            "discarded_article_count": 14
          },
          "sentimentPoints": 2
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 18.2,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 2.7,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": true,
            "vcp_score": 2.7,
            "vcp_reason": "波幅收縮(13%→6.1%)；跌縮量(近10日4日)；站上MA50；升放量(近10日2日)；Ready=Y；Confirm=Y",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 8274040,
              "down_days": 5,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 7929900,
              "avg_vol_20": 8830970,
              "avg_vol_30": 8274040,
              "range_pct_10": 0.061285500747384175,
              "range_pct_20": 0.1101145490782262,
              "range_pct_30": 0.12954658694569016,
              "up_expand_ok": true,
              "lookback_used": 79,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9584072593315962,
              "dist_to_20d_high": 0.05552941176470587,
              "down_shrink_days": 4,
              "breakout_level_20d": 21.25,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.47307692307692295
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 1.6,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.1,
            "details": {
              "atrPct": 3.188839063278525,
              "turnoverUsdM": 146.541105,
              "liquidityPoints": 0.4,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.BAX",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 18.79,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 2.5,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 6.4,
            "take_profit_price": 21.3063,
            "target_multiplier": 1.9,
            "technical_strength": 1.53,
            "take_profit_percent": 6.2
          },
          "positionPoints": 1.1,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 6.37767812655705,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 0.64,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.19
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "弱勢",
      "score": 4,
      "value": -4.67
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.0469
    },
    "kdj": {
      "d": 35.37,
      "j": 62.65,
      "k": 44.47,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 36.57
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 6,
      "trend": "有流入",
      "value": 1232300,
      "recentSlope": 901800,
      "previousSlope": 2481490
    },
    "rsi": 39.63,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 20.8256,
      "position": "SAR喺價上",
      "distancePct": 3.76,
      "previousTrend": "下降"
    },
    "ma50": 19.2466,
    "macd": {
      "macd": 0.09098735722979256,
      "trend": "中性偏多",
      "signal": 0.13894084757911007,
      "histogram": -0.04795349034931751
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 6,
      "value": 20.0464,
      "position": "連續1-2日>VWAP",
      "consecutiveAbove": 1
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.82,
      "score": 4,
      "avgVolume": 8942815,
      "currentVolume": 7301500
    },
    "derived": {
      "ma20": 19.9925,
      "ma50": 19.2466,
      "prevClose": 19.73,
      "avgVolume10": 7768630,
      "avgVolume20": 8942815,
      "changePercent": 1.72,
      "avgVolumeForScore": 8942815
    },
    "ma_cross": {
      "ma20": 19.9925,
      "ma50": 19.2466,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 19.9445,
      "prevMa50": 19.2006,
      "spreadPct": 3.88,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 19.1322,
      "upper": 20.8528,
      "position": "上半部"
    },
    "rsi_short": 50,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.82
    }
  }
}

Raw metrics JSON

{
  "close": 20.07,
  "volume": 7301500,
  "changePercent": 1.72
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.

US.BAX · Baxter International

避免

Score and price trend

Summary

Rolling setup rating

Has the score quality changed?

Signals

Full calculation detail

Market inputs

Metrics snapshot

110-point main rating

基本面 — 2.1/5 · 較差

Sub-items

資金流 — 9.2/20 · 較差

Sub-items

institutional

details

warning

市場環境 — 9.4/15 · 一般

Sub-items

vix

details

trend

details

qqq

spy

催化劑 — 2/20 · 較差

Sub-items

catalyst

details

風險管理 — 6.3/10 · 一般

Sub-items

position

details

stopLevels

strength_details

diversification

details

技術信號 — 18.2/30 · 一般

Sub-items

vcpPayload

vcp_metrics

情緒分析 — 2/10 · 較差

Sub-items

sentiment

details

sentimentData

Dimension contribution

5D momentum v2 breakdown

Risk management

position

details

stopLevels

strength_details

diversification

details

Calculation audit log

Technical indicators

Raw calculation JSON

Raw metrics JSON